David S. Schilansky
Founder chez One Biosciences SAS
Profil
Founder of One Biosciences SAS and Home Biosciences SAS, David S.
Schilansky is Chairman & Chief Executive Officer for Home Biosciences SAS and Chairman for One Biosciences SAS (a subsidiary of Home Biosciences SAS).
Mr. Schilansky previously occupied the position of Chief Operating & Financial Officer for DBV Technologies SA, Group Chief Financial Officer for Ipsen SA Chief Financial Officer for Ipsen Pharma SAS and Head-Investor Relations at Tercica, Inc. (both are subsidiaries of Ipsen SA), Manager-Investor Relations for Ipsen International GmbH and Head-Investor Relations at Technicolor USA, Inc.
Mr. Schilansky received a graduate degree from Université Paris Dauphine-PSL and a graduate degree from Imperial College London.
Postes actifs de David S. Schilansky
Sociétés | Poste | Début |
---|---|---|
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Founder | 01/07/2020 |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Chief Executive Officer | 01/01/2019 |
Anciens postes connus de David S. Schilansky
Sociétés | Poste | Fin |
---|---|---|
LYSOGENE | Director/Board Member | 24/06/2022 |
DBV TECHNOLOGIES | Director of Finance/CFO | - |
IPSEN | Director of Finance/CFO | 01/12/2011 |
Vantiva Usa Shared Services, Inc.
Vantiva Usa Shared Services, Inc. Electronics/AppliancesConsumer Durables Technicolor USA, Inc. manufactures and sells electronic products. It offers wide selection of radio, television, tablets, smart phones, laptop, home accessories, portable audio, and computer products. The company was founded in 1919 and is headquartered in Indianapolis, IN. | Investor Relations Contact | - |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Director of Finance/CFO | - |
Formation de David S. Schilansky
Imperial College London | Graduate Degree |
Université Paris Dauphine-PSL | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
IPSEN | Health Technology |
DBV TECHNOLOGIES | Health Technology |
LYSOGENE | Commercial Services |
Entreprise privées | 6 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Ipsen International GmbH
Ipsen International GmbH Industrial MachineryProducer Manufacturing Ipsen International GmbH manufactures and distributes furnaces and plant systems. Its products include sealed quench furnaces; chamber and multi-purpose chamber furnaces; horizontal and vertical furnaces; EcoFire system; HydroNit Sensor; HybridCarb; and EndoSave system. The firm also provides software processes such as Carb-o-Prof 4.0, AutoMag, Vacu-Prof, and Conti-Control. The company was founded by Harold Ipsen in 1957 and is headquartered in Kleve, Germany. | Producer Manufacturing |
Vantiva Usa Shared Services, Inc.
Vantiva Usa Shared Services, Inc. Electronics/AppliancesConsumer Durables Technicolor USA, Inc. manufactures and sells electronic products. It offers wide selection of radio, television, tablets, smart phones, laptop, home accessories, portable audio, and computer products. The company was founded in 1919 and is headquartered in Indianapolis, IN. | Consumer Durables |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Health Technology |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Health Technology |